Carl Zeiss Meditec AG (CZMWY)
103.99
-0.54
(-0.51%)
USD |
OTCM |
May 15, 15:56
Carl Zeiss Meditec Profit Margin (Quarterly): 9.84% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 9.84% |
December 31, 2023 | 7.87% |
September 30, 2023 | 14.70% |
June 30, 2023 | 17.22% |
March 31, 2023 | 12.30% |
December 31, 2022 | 10.84% |
September 30, 2022 | 18.02% |
June 30, 2022 | 13.10% |
March 31, 2022 | 20.38% |
December 31, 2021 | 9.24% |
September 30, 2021 | 12.05% |
June 30, 2021 | 18.94% |
March 31, 2021 | 13.63% |
December 31, 2020 | 12.55% |
September 30, 2020 | 14.47% |
June 30, 2020 | 2.09% |
March 31, 2020 | 7.27% |
December 31, 2019 | 10.50% |
September 30, 2019 | 11.78% |
June 30, 2019 | 14.10% |
March 31, 2019 | 8.56% |
December 31, 2018 | 8.87% |
September 30, 2018 | 12.57% |
June 30, 2018 | 8.28% |
March 31, 2018 | 8.64% |
Date | Value |
---|---|
December 31, 2017 | 9.67% |
September 30, 2017 | 12.90% |
June 30, 2017 | 11.10% |
March 31, 2017 | 10.04% |
December 31, 2016 | 11.04% |
September 30, 2016 | 10.54% |
June 30, 2016 | 7.67% |
March 31, 2016 | 11.24% |
December 31, 2015 | 6.36% |
September 30, 2015 | 3.43% |
June 30, 2015 | 8.87% |
March 31, 2015 | 4.57% |
December 31, 2014 | 7.60% |
September 30, 2014 | 7.43% |
June 30, 2014 | 8.45% |
March 31, 2014 | 7.79% |
December 31, 2013 | 9.47% |
September 30, 2013 | 9.98% |
June 30, 2013 | 11.65% |
March 31, 2013 | 8.54% |
December 31, 2012 | 10.65% |
September 30, 2012 | 8.25% |
June 30, 2012 | 6.79% |
March 31, 2012 | 10.11% |
December 31, 2011 | 8.04% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
2.09%
Minimum
Jun 2020
20.38%
Maximum
Mar 2022
12.54%
Average
12.42%
Median
Profit Margin (Quarterly) Benchmarks
Affimed NV | -4.89K% |
InflaRx NV | -26.80K% |
MorphoSys AG | 81.70% |
BioNTech SE | -168.0% |
Immatics NV | -164.2% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 13.29% |
Return on Assets | 9.12% |
Return on Invested Capital | 12.54% |
Gross Profit Margin (Quarterly) | 53.49% |
Operating Margin (Quarterly) | 13.71% |
Return on Net Operating Assets | 9.75% |